BamSEC and AlphaSense Join Forces
Learn More

4D Molecular Therapeutics Inc. – Transcripts

NASDAQ: FDMT    
Share price (6/29/26): $12.88    
Market cap (6/29/26): $673 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Other Revised 06/09/26 4D Molecular Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 02:00 PM 06/09/26
Other Revised 06/05/26 4D Molecular Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 03:10 PM 06/03/26
Other Revised 05/22/26 4D Molecular Therapeutics, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 02:35 PM 05/19/26
Other Revised 05/13/26 4D Molecular Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 01:40 PM 05/13/26
Other Revised 03/12/26 4D Molecular Therapeutics, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-12-2026 09:00 AM 03/12/26
Other Revised 03/06/26 4D Molecular Therapeutics, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 10:30 AM 03/03/26
Other Revised 01/14/26 4D Molecular Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 07:30 AM 01/14/26
CY 2025
Other Revised 12/17/25 4D Molecular Therapeutics, Inc. - Special Call 12/17/25
Other Revised 11/21/25 4D Molecular Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 09:00 AM 11/18/25
Other Revised 09/09/25 4D Molecular Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 01:50 PM 09/09/25
Other Revised 06/11/25 4D Molecular Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 11:20 AM 06/11/25
Other Revised 05/14/25 4D Molecular Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 02:20 PM 05/14/25
Other Revised 03/12/25 4D Molecular Therapeutics, Inc. Presents at Barclays 27th Annual Global Healthcare Conference 2025, Mar-12-2025 10:00 AM 03/12/25
Other Revised 02/12/25 4D Molecular Therapeutics, Inc. - Special Call 02/10/25
CY 2024
Other Revised 09/19/24 4D Molecular Therapeutics, Inc. - Special Call 09/18/24
Other Revised 07/17/24 4D Molecular Therapeutics, Inc. - Special Call 07/17/24
Other Revised 06/11/24 4D Molecular Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 02:00 PM 06/11/24
Other Revised 06/06/24 4D Molecular Therapeutics, Inc. - Special Call 06/06/24
Other Revised 05/14/24 4D Molecular Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:40 PM 05/14/24
Other Revised 07/03/24 4D Molecular Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM 03/13/24
Other Revised 02/06/24 4D Molecular Therapeutics, Inc. - Special Call 02/05/24
CY 2023
Other Revised 12/20/23 4D Molecular Therapeutics, Inc. - Special Call 11/01/23
Other Revised 06/12/23 4D Molecular Therapeutics, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 02:00 PM 06/12/23
Other Revised 07/18/23 4D Molecular Therapeutics, Inc. - Special Call 06/07/23
Other Revised 05/10/23 4D Molecular Therapeutics, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 04:20 PM 05/09/23
Other Revised 04/27/23 4D Molecular Therapeutics, Inc. - Special Call 04/27/23
Other Revised 02/22/23 4D Molecular Therapeutics, Inc. - Special Call 02/22/23
CY 2022
Other Revised 11/14/22 4D Molecular Therapeutics, Inc. - Special Call 11/14/22
Other Revised 11/03/22 4D Molecular Therapeutics, Inc. - Special Call 11/03/22
Other Revised 06/15/22 4D Molecular Therapeutics, Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-15-2022 08:40 AM 06/15/22
Other Revised 05/10/22 4D Molecular Therapeutics, Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-2022 08:40 AM 05/10/22
CY 2021
Other Revised 10/25/21 4D Molecular Therapeutics, Inc. - Special Call 10/25/21